Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: Study of JROSG (Japan Radiation Oncology Study Group)

References

• NCI Clinical Announcement R, MD. UD Dept of Health and Human Services Public Health Service. National Insitututes of Health 1999.
   Google Scholar
• Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 2001; 358(9284)781–6
   PubMed Web of Science ®Google Scholar
• Kirwan JM, Symonds P, Green JA, Tierney J, Collingwood M, Williams CJ. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003; 68: 217–26
   PubMed Web of Science ®Google Scholar
• Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004; 22: 872–80
   PubMed Web of Science ®Google Scholar
• Potter R, Dimopoulos J, Bachtiary B, Sissolak G, Klos B, Rheinthaller A, et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol 2006; 79: 80–6
   PubMedGoogle Scholar
• Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154–61
   PubMed Web of Science ®Google Scholar
• Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137–43
   PubMed Web of Science ®Google Scholar
• Peters WA, 3rd, Liu PY, Barrett RJ2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606–13
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144–53
   PubMed Web of Science ®Google Scholar
• Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339–48
   PubMed Web of Science ®Google Scholar
• Teshima T, Chatani M, Inoue T. Remote afterloading high-dose rate intracavitary therapy of carcinoma of the uterine cervix. I. Survival, prognostic factors, cause of death and patterns of failure and complication. Nippon Igaku Hoshasen Gakkai Zasshi–Nippon Acta Radiologica 1987; 47: 821–8
   PubMedGoogle Scholar
• Arai T, Nakano T, Morita S, Sakashita K, Nakamura YK, Fukuhisa K. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience. Cancer 1992; 69: 175–80
   PubMed Web of Science ®Google Scholar
• Shigematsu Y, Nishiyama K, Masaki N, Inoue T, Miyata Y, Ikeda H, et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: A comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys 1983; 9: 351–6
   PubMed Web of Science ®Google Scholar
• 38 IR. Dose and volume specification for reporting intracavitary therapy in gynecology. 1985.
   Google Scholar
• Nag S, Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 2000; 46: 507–13
   PubMed Web of Science ®Google Scholar
• Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985; 58(690)515–28
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Non-parametric estimates from incomplete observations. J Am Stat Assoc 1953; 53: 457–80
   Google Scholar
• Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187–220
   Google Scholar
• Rose PG, Eifel PJ. Combined radiation therapy and chemotherapy for carcinoma of the cervix. Cancer J 2001; 7: 86–94
   PubMedGoogle Scholar
• Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966–72
   PubMed Web of Science ®Google Scholar
• Clark BG, Souhami L, Roman TN, Evans MD, Pla C. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: A dosimetric analysis. Int J Radiat Oncol Biol Phys 1994; 28: 1243–50
   PubMedGoogle Scholar
• Malviya VK, Han I, Deppe G, Malone JM, Jr, Christensen CW, Kim Y, et al. High-dose-rate afterloading brachytherapy, external radiation therapy, and combination chemotherapy in poor-prognosis cancer of the cervix. Gynecol Oncol 1991; 42: 233–8
   PubMedGoogle Scholar
• Sood BM, Gorla G, Gupta S, Garg M, Deore S, Runowicz CD, et al. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: Clinical experience with and without chemotherapy. Int J Radiat Oncol Biol Phys 2002; 53: 702–6
   PubMedGoogle Scholar
• Souhami L, Seymour R, Roman TN, Stanimir GW, Trudeau M, Clark BG, et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993; 27: 871–8
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Kirisits C, Petric P, Georg P, Lang S, Berger D, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006; 66: 83–90
   PubMed Web of Science ®Google Scholar